CXCL8 and infection: Tulobuterol (0.1 μmol/L) reduced the baseline secretion of IL-1β, IL-6, and IL-8 for 24 h before RV14 infection compared with the levels observed in cells treated with vehicle (0.001% ethanol) (Fig. 5).